Lennar Corporation LEN has seen its stock drop 26.2% over the past three months, significantly underperforming its industry ...
Amneal Pharmaceuticals (AMRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...